Literature DB >> 6793214

Neuron-specific enolase in relation to differentiation in human neuroblastoma.

L Odelstad, S Påhlman, K Nilsson, E Larsson, G Läckgren, K E Johansson, S Hjertén, G Grotte.   

Abstract

The presence of the two forms of enolase, neuron-specific enolase (NSE) and non-neuronal enolase (NNE), have been examined in biopsy material of human neuroblastoma, ganglioneuroblastoma, ganglioneuroma and cultured neuroblastoma cells, after separation with ion exchange chromatography. The enolase activities were inhibited in the presence of NaCl but remained active in KCl, which were used in the chromatographic step. The relative NSE levels in the neuroblastoma tissues were found to be lower than in the histopathologically more differentiated forms of the tumour, i.e. ganglioneuroblastoma and ganglioneuroma. The human neuroblastoma in vitro cell lines SK-N-SH, SH-SY5Y, SK-N-MC and IMR-32 contained considerably lower relative levels of NSE compared to the levels in the neuroblastoma biopsies. After treatment of the cultured cells with nerve growth factor or dibutyryl-cAMP some cells showed morphological differentiation and concomitantly an increase in the NSE levels. The results indicate that NSE might be useful as a marker for differentiation in human neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6793214     DOI: 10.1016/0006-8993(81)91117-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Neuron specific enolase (NSE) and thymidine kinase (TK) as markers in biological fluids of brain tumor patients.

Authors:  A Boiardi; L Munari; A Silvani; C L Solero; E Bombardieri
Journal:  Ital J Neurol Sci       Date:  1990-08

Review 2.  The correlation of neoplastic vulnerability with central neuroepithelial cytogeny and glioma differentiation.

Authors:  L J Rubinstein
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

3.  Localization of neuron-specific (gamma gamma) enolase in proliferating (supportive and neoplastic) Schwann cells. An immunohisto- and electron-immunocyto-chemical study of ganglioneuroblastoma and schwannomas.

Authors:  S A Vinores; M M Herman; L J Rubinstein
Journal:  Histochem J       Date:  1987-08

Review 4.  Malignancy markers in the cerebrospinal fluid.

Authors:  M Koskiniemi
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

5.  Inhibition of brain enolases by acrylamide and its related compounds in vitro, and the structure-activity relationship.

Authors:  H Tanii; K Hashimoto
Journal:  Experientia       Date:  1984-09-15

6.  Contributions of immunohistochemistry to the problem of differentiation in medulloblastoma.

Authors:  M T Giordana; A Mauro; A Migheli; D Schiffer
Journal:  Ital J Neurol Sci       Date:  1983-12

7.  A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation.

Authors:  M Lanciotti; P G Montaldo; S Folghera; E Lucarelli; P Cornaglia-Ferraris; M Ponzoni
Journal:  Cell Mol Neurobiol       Date:  1992-06       Impact factor: 5.046

8.  The MT1G Gene in LUHMES Neurons Is a Sensitive Biomarker of Neurotoxicity.

Authors:  Zhi-Bin Tong; John Braisted; Pei-Hsuan Chu; David Gerhold
Journal:  Neurotox Res       Date:  2020-09-01       Impact factor: 3.911

9.  Distribution of neurofilament protein and neuron-specific enolase in peripheral neuronal tumours.

Authors:  A Sasaki; A Ogawa; Y Nakazato; Y Ishida
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Dimethyl sulfoxide-induced differentiation does not alter tumorigenicity of neuroblastoma cells.

Authors:  Y L Danon; E Kaminsky
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.